First Tracks Biotherapeutics, Inc. (TRAX)
Who owns First Tracks Biotherapeutics, Inc. (TRAX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 89.0% of the shares are freely tradable; institutional investors hold 46.0%.
Ownership Structure
Largest Shareholders
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.20 | 768,570 | +0.0 | 04/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 1.61 | 560,155 | -0.6 | 05/31/2026 |
| iShares Russell 2000 ETF | 1.26 | 441,240 | +0.9 | 05/29/2026 |
| Nuveen Quant Small Cap Equity R6 | 0.77 | 269,060 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.63 | 221,331 | +0.0 | 04/30/2026 |
| Fidelity Advisor Biotechnology I | 0.43 | 148,400 | +0.0 | 04/30/2026 |
| iShares Russell 2000 Growth ETF | 0.42 | 148,222 | -0.6 | 05/29/2026 |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 0.35 | 121,994 | +0.0 | 05/31/2026 |
| Fidelity Extended Market Index | 0.30 | 104,369 | +0.0 | 04/30/2026 |
| Schwab US Small-Cap ETF™ | 0.27 | 94,549 | +0.1 | 05/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.